|
|
Volumn 83, Issue 2, 1999, Pages 415-443
|
|
Dopamine agonists
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOMORPHINE;
BROMOCRIPTINE;
BROMOCRIPTINE MESILATE;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERYTHROMYCIN;
LEVODOPA;
LISURIDE;
PERGOLIDE;
PERGOLIDE MESILATE;
PRAMIPEXOLE;
ROPINIROLE;
WARFARIN;
CLINICAL TRIAL;
DOPAMINE METABOLISM;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NEUROPROTECTION;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RECEPTOR SENSITIVITY;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0033038256
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-7125(05)70112-7 Document Type: Article |
|
Times cited : (51)
|
|
References (94)
|
